QUDEXY

NDC 0245-1075 · Upsher-Smith Laboratories, LLC

Generic nameTopiramate

Dosage formCAPSULE, EXTENDED RELEASE

RouteORAL

Active ingredient(s)TOPIRAMATE

Strength150 mg/1

Pharmacologic classCytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]

Marketing categoryNDA

Packages

0245-1075-30 — 1 BOTTLE in 1 CARTON (0245-1075-30) / 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE

0245-1075-90 — 1 BOTTLE in 1 CARTON (0245-1075-90) / 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0245-1071 — Topiramate, 0245-1072 — Topiramate, 0245-1073 — Topiramate, 0245-1074 — Topiramate, 0480-2299 — Phentermine and topiramate, 0480-2356 — Topiramate, 0480-2357 — Topiramate, 0480-2358 — Topiramate, 0480-2359 — Topiramate, 0480-3295 — Phentermine and topiramate, 0480-3296 — Phentermine and topiramate, 0480-3297 — Phentermine and topiramate, 0615-8593 — Topiramate, 0615-8594 — Topiramate, 0615-8595 — Topiramate, 0832-1071 — Topiramate, 0832-1072 — Topiramate, 0832-1073 — Topiramate, 0832-1074 — Topiramate, 0832-1075 — Topiramate, +289 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.